Double Bond Pharmaceutical International AB

Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The company's business focus is on the treatment of cancer, infections and autoimmune diseases. The research is based on the company's proprietary drug-delivery technology. The products are sold under separate brands and product development collaborations take place with other players in the industry. The company is headquartered in Uppsala.

Quotes

Board

CEO

  • Igor Lokot

Chairperson of the Board

  • Sanna Rejnlander

Board

  • Igor Lokot
  • Irina Zaitseva
  • Sergey Yanitsky
Articles of association

Videos

1 / 4
Sitdown Double Bond sitdown
CompanyPresentation BeloGal® and SA-033 (svenska)
CompanyPresentation BeloGal® and SA-033 (english)
CompanyPresentation Aktiespararna intervjuar VD Igor Lokot
** Powered by Modular Finance
*Powered by Modular Finance
Key Numbers
2026-06-30 2026-03-31 2025-12-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Number of months that the report spans Q2 3 Months Q1 3 Months 2025 Q4 3 Months Q3 3 Months Q2 3 Months Q1 3 Months
Total revenue MSEK 0.00 0.05 0.08 0.02 0.06 0.00 0.00
Earnings before interest and tax MSEK -0.61 -0.27 -1.69 -0.46 -0.47 -0.37 -0.40
Profit before tax MSEK -0.61 -0.27 -0.33 1.68 -0.47 -0.44 -1.10
Net profit MSEK -0.61 -0.27 -0.33 1.68 -0.47 -0.44 -1.10
Earnings per share SEK 0.00 0.00 0.00 0.01 -0.01 -0.01 -0.01
Dividend per share SEK 0,00 0,00 0.00 0.00 0,00 0,00 0,00
Equity MSEK 14.29 13.91 14.21 14.21 11.53 2.46 2.90
Fixed assets MSEK 0.00 0.01 0.02 0.02 0.04 0.05 0.07
Intangible assets MSEK 15.79 14.33 12.49 12.49 10.88 9.56 7.94
Current assets MSEK 1.41 2.06 4.17 4.17 2.99 1.97 3.76
Total asset MSEK 17.20 16.40 16.69 16.69 13.90 11.58 11.76
Long term liabilities MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current liabilities MSEK 2.90 2.49 2.48 2.48 2.37 9.12 8.86
Number of shares SEK 222849706.00 214302697.00 205755688.00 205755688.00 205755688.00 107120108.00 107120108.00
*Compiled data from Millistream